{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:13:47Z","timestamp":1785838427415,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"T.D. is employed by Arbor Biotechnologies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The CRISPR-Cas type V-I is a family of Cas12i-containing programmable nuclease systems guided by a short crRNA without requirement for a tracrRNA. Here we present an engineered Type V-I CRISPR system (Cas12i), ABR-001, which utilizes a tracr-less guide RNA. The compact Cas12i effector is capable of self-processing pre-crRNA and cleaving dsDNA targets, which facilitates versatile delivery options and multiplexing, respectively. We apply an unbiased mutational scanning approach to enhance initially low editing activity of Cas12i2. The engineered variant, ABR-001, exhibits broad genome editing capability in human cell lines, primary T cells, and CD34+ hematopoietic stem and progenitor cells, with both robust efficiency and high specificity. In addition, ABR-001 achieves a high level of genome editing when delivered via AAV vector to HEK293T cells. This work establishes ABR-001 as a versatile, specific, and high-performance platform for ex vivo and in vivo gene therapy.<\/jats:p>","DOI":"10.1038\/s41467-022-30465-7","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T10:04:24Z","timestamp":1653041064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing"],"prefix":"10.1038","volume":"13","author":[{"given":"Colin","family":"McGaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Garrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle Z.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Haswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejuti","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Keston-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratyusha","family":"Hunnewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishti","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-4454","authenticated-orcid":false,"given":"Quinton","family":"Wessells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Jakimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Alfonse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Ziblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Carte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Cerchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugapriya","family":"Sothiselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston X.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-300X","authenticated-orcid":false,"given":"Tia","family":"DiTommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"30465_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","volume":"45","author":"D Bhaya","year":"2011","unstructured":"Bhaya, D., Davison, M. & Barrangou, R. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu. Rev. Genet. 45, 273\u2013297 (2011).","journal-title":"Annu. Rev. Genet."},{"key":"30465_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","volume":"18","author":"KS Makarova","year":"2020","unstructured":"Makarova, K. S. et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67\u201383 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"30465_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1089\/crispr.2021.0021","volume":"4","author":"MA Nethery","year":"2021","unstructured":"Nethery, M. A. et al. CRISPRclassify: repeat-based classification of CRISPR loci. CRISPR J. 4, 558\u2013574 (2021).","journal-title":"CRISPR J."},{"key":"30465_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30465_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262\u20131278 (2014).","journal-title":"Cell"},{"key":"30465_CR6","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).","journal-title":"Science"},{"key":"30465_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aav7271","volume":"363","author":"WX Yan","year":"2019","unstructured":"Yan, W. X. et al. Functionally diverse type V CRISPR-Cas systems. Science 363, 88\u201391 (2019).","journal-title":"Science"},{"key":"30465_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759\u2013771 (2015).","journal-title":"Cell"},{"key":"30465_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.molcel.2018.06.043","volume":"71","author":"I Strohkendl","year":"2018","unstructured":"Strohkendl, I., Saifuddin, F. A., Rybarski, J. R., Finkelstein, I. J. & Russell, R. Kinetic basis for DNA target specificity of CRISPR-Cas12a. Mol. Cell 71, 816\u2013824 e813 (2018).","journal-title":"Mol. Cell"},{"key":"30465_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nbt.3620","volume":"34","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat. Biotechnol. 34, 869\u2013874 (2016).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nbt.3609","volume":"34","author":"D Kim","year":"2016","unstructured":"Kim, D. et al. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat. Biotechnol. 34, 863\u2013868 (2016).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08224-4","volume":"10","author":"J Strecker","year":"2019","unstructured":"Strecker, J. et al. Engineering of CRISPR-Cas12b for human genome editing. Nat. Commun. 10, 212 (2019).","journal-title":"Nat. Commun."},{"key":"30465_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-018-0011-0","volume":"37","author":"BP Kleinstiver","year":"2019","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276\u2013282 (2019).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR14","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol. Cell 81, 4333\u20134345 (2021).","DOI":"10.1016\/j.molcel.2021.08.008"},{"key":"30465_CR15","doi-asserted-by":"publisher","first-page":"14031","DOI":"10.1021\/ja502512g","volume":"136","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. Engineering bacterial transcription regulation to create a synthetic in vitro two-hybrid system for protein interaction assays. J. Am. Chem. Soc. 136, 14031\u201314038 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"30465_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.molcel.2017.12.007","volume":"69","author":"R Marshall","year":"2018","unstructured":"Marshall, R. et al. Rapid and scalable characterization of CRISPR technologies using an E. coli cell-free transcription-translation system. Mol. Cell 69, 146\u2013157 e143 (2018).","journal-title":"Mol. Cell"},{"key":"30465_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molcel.2016.06.037","volume":"63","author":"M van Overbeek","year":"2016","unstructured":"van Overbeek, M. et al. DNA repair profiling reveals nonrandom outcomes at Cas9-mediated breaks. Mol. Cell 63, 633\u2013646 (2016).","journal-title":"Mol. Cell"},{"key":"30465_CR18","doi-asserted-by":"crossref","unstructured":"Cofsky, J. C. et al CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks. Elife 9, e55143 (2020).","DOI":"10.7554\/eLife.55143"},{"key":"30465_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2020.02.023","volume":"78","author":"JL Schmid-Burgk","year":"2020","unstructured":"Schmid-Burgk, J. L. et al. Highly parallel profiling of Cas9 variant specificity. Mol. Cell 78, 794\u2013800 e798 (2020).","journal-title":"Mol. Cell"},{"key":"30465_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver, M. C. et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527, 192\u2013197 (2015).","journal-title":"Nature"},{"key":"30465_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","volume":"173","author":"N Liu","year":"2018","unstructured":"Liu, N. et al. Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173, 430\u2013442 e417 (2018).","journal-title":"Cell"},{"key":"30465_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/crispr.2018.0033","volume":"1","author":"KS Makarova","year":"2018","unstructured":"Makarova, K. S., Wolf, Y. I. & Koonin, E. V. Classification and nomenclature of CRISPR-Cas systems: where from Here? CRISPR J. 1, 325\u2013336 (2018).","journal-title":"CRISPR J."},{"key":"30465_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"30465_CR26","doi-asserted-by":"crossref","unstructured":"Xu, C. L., Ruan M. Z. C., Mahajan V. B. & Tsang S. H. Viral delivery systems for CRISPR. Viruses 11, 28 (2019).","DOI":"10.3390\/v11010028"},{"key":"30465_CR27","unstructured":"Stadtmauer, E. A. et al. CRISPR-engineered T cells in patients with refractory cancer. Science 367, eaba7365 (2020)."},{"key":"30465_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia. N. Engl. J. Med. 384, 252\u2013260 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30465_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24017-8","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines. Nat. Commun. 12, 3908 (2021).","journal-title":"Nat. Commun."},{"key":"30465_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19072-6","volume":"11","author":"X Huang","year":"2020","unstructured":"Huang, X. et al. Structural basis for two metal-ion catalysis of DNA cleavage by Cas12i2. Nat. Commun. 11, 5241 (2020).","journal-title":"Nat. Commun."},{"key":"30465_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23876-5","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1. Nat. Commun. 12, 3476 (2021).","journal-title":"Nat. Commun."},{"key":"30465_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen, J. S. et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550, 407\u2013410 (2017).","journal-title":"Nature"},{"key":"30465_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84\u201388 (2016).","journal-title":"Science"},{"key":"30465_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.abb1400","volume":"369","author":"P Pausch","year":"2020","unstructured":"Pausch, P. et al. CRISPR-CasPhi from huge phages is a hypercompact genome editor. Science 369, 333\u2013337 (2020).","journal-title":"Science"},{"key":"30465_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41594-021-00632-3","volume":"28","author":"P Pausch","year":"2021","unstructured":"Pausch, P. et al. DNA interference states of the hypercompact CRISPR-CasPhi effector. Nat. Struct. Mol. Biol. 28, 652\u2013661 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"30465_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/bs.mie.2021.05.010","volume":"659","author":"C McGaw","year":"2021","unstructured":"McGaw, C. & Chong, S. Cell-free protein synthesis of CRISPR ribonucleoproteins (RNP). Methods Enzymol. 659, 371\u2013389 (2021).","journal-title":"Methods Enzymol."},{"key":"30465_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."},{"key":"30465_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/90802","volume":"19","author":"Y Shimizu","year":"2001","unstructured":"Shimizu, Y. et al. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19, 751\u2013755 (2001).","journal-title":"Nat. Biotechnol."},{"key":"30465_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymeth.2005.04.006","volume":"36","author":"Y Shimizu","year":"2005","unstructured":"Shimizu, Y., Kanamori, T. & Ueda, T. Protein synthesis by pure translation systems. Methods 36, 299\u2013304 (2005).","journal-title":"Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30465-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30465-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30465-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:18:59Z","timestamp":1669310339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30465-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30465"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30465-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M., A.J.G., G.Z.M., J.R.H., S.S., E.K.S., M.B., A.O., Q.W., N.J., P.Y., H.Z., L.E.A., R.Z., D.R.C., and T.D. are current employees and shareholders of Arbor Biotechnologies (Arbor). W.X.Y. and D.A.S are co-founders and shareholders of Arbor. P.H., J.M.C., W.L., D.C., B.H., S.So., and S.C. are former Arbor employees and were employed when this work was conducted. Some of the content in the manuscript has been included in a patent application published as WO 2021202800 on October 7, 2021. S.C., B.H., Q.W. N.J., R.Z., J.M.C, T.D., J.R.H., A.J.G., C.M., D.A.S., and D.C. are listed as inventors on WO 2021202800.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2833"}}